Lentivector targeting to dendritic cells

Molecular Therapy

Volumn 16, Issue 6, 2008, Pages 1008-1009

  Ageichik, Alexander ^a   Collins, Mary K ^a   Dewannieux, Marie ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; CD209 ANTIGEN; DENDRITIC CELL VACCINE; GLYCOPROTEIN E1; LENTIVIRUS VACCINE; LENTIVIRUS VECTOR; SINDBIS GLYCOPROTEIN; SINDBIS VECTOR; VIRUS GLYCOPROTEIN; VIRUS VACCINE; VIRUS VECTOR;

ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; CANCER IMMUNIZATION; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; GENE TARGETING; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; NONHUMAN; NOTE; PROMOTER REGION; VIRAL GENE DELIVERY SYSTEM;

EID: 44349103761     PISSN: 15250016     EISSN: 15250024     Source Type: Journal    
DOI: 10.1038/mt.2008.95     Document Type: Note

References (15)

1. Steinman, RM and Banchereau, J (2007). Taking dendritic cells into medicine. Nature 449: 419-426.
2. Tacken, PJ, de Vries, IJ, Torensma, R and Figdor, CG (2007). Dendritic-cell immunotherapy: From ex vivo loading to in vivo targeting. Nat Rev Immunol 7: 790-802.
3. Bonifaz, LC, Bonnyay, DP, Charalambous, A, Darguste, DI, Fujii, S, Soares, H et al. (2004). In vivo targeting of antigens to maturing dendritic cells via the DEC-205 receptor improves T cell vaccination. J Exp Med 199: 815-824.
4. Cheng, C, Gall, JG, Kong, WP, Sheets, RL, Gomez, PL, King, CR et al. (2007). Mechanism of ad5 vaccine immunity and toxicity: Fi ber shaft targeting of dendritic cells. PLoS Pathog 3: E25.
5. Martin, F, Neil, S, Kupsch, J, Maurice, M, Cosset, F and Collins, M (1999). Retrovirus targeting by tropism restriction to melanoma cells. J Virol 73: 6923-6929.
6. Ohno, K, Sawai, K, Iijima, Y, Levin, B and Meruelo, D (1997). Cell-specifi c targeting of Sindbis virus vectors displaying IgG-binding domains of protein A. Nat Biotechnol 15: 763-767.
7. Nakamura, T, Peng, KW, Harvey, M, Greiner, S, Lorimer, IA, James, CD et al. (2005). Rescue and propagation of fully retargeted oncolytic measles viruses. Nat Biotechnol 23: 209-214.
8. Morizono, K, Xie, Y, Ringpis, GE, Johnson, M, Nassanian, H, Lee, B et al. (2005). Lentiviral vector retargeting to P-glycoprotein on metastatic melanoma through intravenous injection. Nat Med 11 346-352.
9. Esslinger, C, Chapatte, L, Finke, D, Miconnet, I, Guillaume, P, Lévy, F et al. (2003). In vivo administration of a lentiviral vaccine targets DCs and induces effi cient CD8(+) T cell responses. J Clin Invest 111: 1673-1681.
10. Palmowski, MJ, Lopes, L, Ikeda, Y, Salio, M, Cerundolo, V and Collins, MK (2004). Intravenous injection of a lentiviral vector encoding NY-ESO-1 induces an effective CTL response. J Immunol 172: 1582-1587.
11. He, Y, Zhang, J, Mi, Z, Robbins, P and Falo, LD Jr (2005). Immunization with lentiviral vector-transduced dendritic cells induces strong and long-lasting T cell responses and therapeutic immunity. J Immunol 174: 3808-3817.
12. Yang, L, Yang, H, Rideout, K, Cho, T, Joo, KI, Ziegler, L et al. (2008). Engineered lentivector targeting of dendritic cells for in vivo immunization. Nat Biotechnol 26: 326-334.
13. + T-cell responses. J Virol 82: 86-95.
14. de Witte, L, Nabatov, A and Geijtenbeek, TB (2008). Distinct roles for DC-SIGN(+)-dendritic cells and Langerhans cells in HIV-1 transmission. Trends Mol Med 14: 12-19.
15. Escors, D, Lopes, L, Lin, R, Hiscott, J, Akira, S, Davis, RJ et al. (2008). Targeting dendritic cell signaling to regulate the response to immunization. Blood 111: 3050-3061.